Ghent University Academic Bibliography

Add to list

Journal Article
A1
open access

Fighting fire with fire : the immune system might be key in our fight against Alzheimer’s disease

Pieter Dujardin (UGent) , Roosmarijn Vandenbroucke (UGent) and Lien Van Hoecke (UGent)

(2022) DRUG DISCOVERY TODAY. 27(5). p.1261-1283

Add to list

Journal Article
A1
open access

Recent insights into viral infections as a trigger and accelerator in Alzheimer's disease

Lize De Vlieger (UGent) , Roosmarijn Vandenbroucke (UGent) and Lien Van Hoecke (UGent)

(2022) DRUG DISCOVERY TODAY. 27(11).

Add to list

Non-invasive cell-tracking methods for adoptive T cell therapies

Jelter Van Hoeck, Christian Vanhove (UGent) , Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)

(2022) DRUG DISCOVERY TODAY. 27(3). p.793-807

Add to list

Müller cells as a target for retinal therapy

Joke Devoldere (UGent) , Karen Peynshaert (UGent) , Stefaan De Smedt (UGent) and Katrien Remaut (UGent)

(2019) DRUG DISCOVERY TODAY. 24(8). p.1483-1498

Add to list

Journal Article
A1
open access

Evading innate immunity in nonviral mRNA delivery : don't shoot the messenger

Joke Devoldere (UGent) , Heleen Dewitte (UGent) , Stefaan De Smedt (UGent) and Katrien Remaut (UGent)

(2016) DRUG DISCOVERY TODAY. 21(1). p.11-25

Add to list

Nanobodies as therapeutics: big opportunities for small antibodies

Sophie Steeland (UGent) , Roosmarijn Vandenbroucke (UGent) and Claude Libert (UGent)

(2016) DRUG DISCOVERY TODAY. 21(7). p.1076-1113

Add to list

Journal Article
A1
open access

Using transcriptomics to guide lead optimization in drug discovery projects : lessons learned from the QSTAR project

Bie Verbist (UGent) , Günter Klambauer, Liesbet Vervoort, Willem Talloen, Ziv Shkedy, Olivier Thas (UGent) , Andreas Bender, Hinrich WH Göhlmann, Sepp Hochreiter, the QSTAR Consortium, et al.

(2015) DRUG DISCOVERY TODAY. 20(5). p.505-513

Add to list

Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disorders

Delphine Demeestere (UGent) , Claude Libert (UGent) and Roosmarijn Vandenbroucke (UGent)

(2015) DRUG DISCOVERY TODAY. 20(8). p.928-941

Add to list

Matrix metalloproteinases as drug targets in ischemia/reperfusion injury

Eline Dejonckheere (UGent) , Roosmarijn Vandenbroucke (UGent) and Claude Libert (UGent)

(2011) DRUG DISCOVERY TODAY. 16(17-18). p.762-778

Add to list

Particulate vaccines: on the quest for optimal delivery and immune response

Marie-Luce De Temmerman (UGent) , Joanna Rejman (UGent) , Jo Demeester (UGent) , Darrell J Irvine, Bruno Gander and Stefaan De Smedt (UGent)

(2011) DRUG DISCOVERY TODAY. 16(13-14). p.569-582

Academic Bibliography

Fighting fire with fire : the immune system might be key in our fight against Alzheimer’s disease

Recent insights into viral infections as a trigger and accelerator in Alzheimer's disease

Non-invasive cell-tracking methods for adoptive T cell therapies

Müller cells as a target for retinal therapy

Evading innate immunity in nonviral mRNA delivery : don't shoot the messenger

Nanobodies as therapeutics: big opportunities for small antibodies

Using transcriptomics to guide lead optimization in drug discovery projects : lessons learned from the QSTAR project

Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disorders

Matrix metalloproteinases as drug targets in ischemia/reperfusion injury

Particulate vaccines: on the quest for optimal delivery and immune response

Contents

Support

Contact